Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-17
2011-10-18
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S471000, C548S472000
Reexamination Certificate
active
08039506
ABSTRACT:
The present invention provides novel bicyclic lactams derivatives, and analogues thereof, of Formula (I):or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables A, B, C, W, Y, Z1, Z2, Z3, Z4, R8, and R9are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.
REFERENCES:
patent: 6642252 (2003-11-01), Bisacchi et al.
patent: 7122559 (2006-10-01), Glunz et al.
patent: 7144895 (2006-12-01), Bisacchi et al.
patent: 7456195 (2008-11-01), Zhang et al.
patent: 2006/0166997 (2006-07-01), Zhang et al.
patent: 2007/0208054 (2007-09-01), Priestley et al.
patent: 2009/0131473 (2009-05-01), Nirschl et al.
patent: WO2006/076246 (2006-07-01), None
patent: WO2007/146719 (2007-12-01), None
patent: WO2008/079836 (2008-07-01), None
Carson, S.D. et al., “The role of tissue factor in the production of thrombin”, Blood Coagulation and Fibrinolysis, vol. 4, pp. 281-292 (1993).
Giesen, P. et al., “Blood-borne tissue factor: Another view of thrombosis”, PNAS, vol. 96, pp. 2311-2315 (1999).
Himber, J. et al., “Inhibition of tissue factor limits the growth of venous thrombus in the rabbit”, J. of Thrombosis and Haemostasis, vol. 1, pp. 889-895 (2003).
Hoffman, M., “A cell-based model of coagulation and the role of factor VIIa”, Blood Reviews, vol. 17, pp. S1-S5 (2003).
Kranjc A. et al., “recent Advances in the Discovery of Tissue Factor/Factor VIIA inhibitors and Dual Inhibitors of Factor VIIA/Factor XA”, Current Pharmaceutical Design, vol. 11(32), pp. 4207-4227 (2005).
Lazarus, R. et al., “Inhibitors of tissue factor, Factor VIIA for Anticoagulant therapy”, Current Medicinal Chemistry, vol. 11(18), pp. 2275-2290 (2004).
Morrissey, JH., “Tissue factor: in at the start . . . and the finish?”, Journal of Thrombosis and Haemostasis, vol. 1 pp. 878-880 (2003).
Morrissey, JH. et al., “Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation”, Blood, vol. 81, pp. 734-744 (1993).
Cheney Daniel L.
Ladziata Vladimir
Parkhurst Brandon
Priestley Eldon Scott
Wurtz Nicholas Ronald
Bristol--Myers Squibb Company
McDowell Brian
Sun Jing G.
Wilson James O
LandOfFree
Bicyclic lactam factor VIIa inhibitors useful as anticoagulants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic lactam factor VIIa inhibitors useful as anticoagulants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic lactam factor VIIa inhibitors useful as anticoagulants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4294693